| Fecha | Hora | Fuente | Título | Símbolo | Compañía |
| 24/02/2011 | 05:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 23/02/2011 | 15:40 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 22/02/2011 | 16:06 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |
| 18/02/2011 | 15:09 | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
| 18/02/2011 | 15:05 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 18/02/2011 | 15:02 | Edgar (US Regulatory) | -National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25) | NYSE:KG | King Pharmaceuticals, Inc. |
| 15/02/2011 | 16:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:KG | King Pharmaceuticals, Inc. |
| 15/02/2011 | 10:57 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
| 14/02/2011 | 12:52 | Edgar (US Regulatory) | Schedule 13G | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 13:36 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 05:08 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NYSE:KG | King Pharmaceuticals, Inc. |
| 09/02/2011 | 17:08 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 08/02/2011 | 08:32 | Marketwired | King Pharmaceuticals, Inc. Announces Intent to Voluntarily Delist From the New York Stock Exchange | NYSE:KG | King Pharmaceuticals, Inc. |
| 31/01/2011 | 15:23 | Edgar (US Regulatory) | Tender offer statement by Issuer (SC TO-I) | NYSE:KG | King Pharmaceuticals, Inc. |
| 31/01/2011 | 15:05 | Marketwired | King Pharmaceuticals, Inc. Announces Offer to Purchase Any and All of Its Outstanding 1 1/4% Convertible Senior Notes Due 2026 T | NYSE:KG | King Pharmaceuticals, Inc. |
| 31/01/2011 | 08:20 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NYSE:KG | King Pharmaceuticals, Inc. |
| 31/01/2011 | 08:06 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NYSE:KG | King Pharmaceuticals, Inc. |
| 27/01/2011 | 07:45 | PR Newswire (US) | REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 | NYSE:KG | King Pharmaceuticals, Inc. |
| 25/01/2011 | 08:59 | PR Newswire (US) | Zacks Analyst Blog Highlights: Pfizer, King Pharmaceuticals, Durect Pharma, Pain Therapeutics and Acura Pharmaceuticals | NYSE:KG | King Pharmaceuticals, Inc. |
| 21/01/2011 | 08:25 | Dow Jones News | Pfizer Again Extends Offer For King Pharma; Fewer Shares Tendered | NYSE:KG | King Pharmaceuticals, Inc. |
| 20/01/2011 | 17:06 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NYSE:KG | King Pharmaceuticals, Inc. |
| 27/12/2010 | 07:30 | GlobeNewswire Inc. | King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY(R) | NYSE:KG | King Pharmaceuticals, Inc. |
| 27/12/2010 | 06:58 | Dow Jones News | King Pharma Resubmits FDA Application For Remoxy | NYSE:KG | King Pharmaceuticals, Inc. |
| 27/12/2010 | 06:15 | PR Newswire (US) | REMOXY® New Drug Application Resubmitted | NYSE:KG | King Pharmaceuticals, Inc. |
| 27/12/2010 | 06:00 | PR Newswire (US) | King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® | NYSE:KG | King Pharmaceuticals, Inc. |
| 20/12/2010 | 07:59 | Marketwired | Brian Markison to Join Rosetta Genomics Board of Directors | NYSE:KG | King Pharmaceuticals, Inc. |
| 20/12/2010 | 06:00 | PR Newswire (US) | King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX® Tablets | NYSE:KG | King Pharmaceuticals, Inc. |
| 16/12/2010 | 14:25 | Dow Jones News | S&P 500 Rings In New Year With Higher-Tech, Larger-Cap Names | NYSE:KG | King Pharmaceuticals, Inc. |
| 15/12/2010 | 16:45 | Dow Jones News | Pfizer Again Extends Deadline On King Tender Offer | NYSE:KG | King Pharmaceuticals, Inc. |
| 15/12/2010 | 16:01 | PR Newswire (US) | Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc. | NYSE:KG | King Pharmaceuticals, Inc. |